JP2017503505A5 - - Google Patents

Info

Publication number

JP2017503505A5

JP2017503505A5 JP2016545811A JP2016545811A JP2017503505A5 JP 2017503505 A5 JP2017503505 A5 JP 2017503505A5 JP 2016545811 A JP2016545811 A JP 2016545811A JP 2016545811 A JP2016545811 A JP 2016545811A JP 2017503505 A5 JP2017503505 A5 JP 2017503505A5

Authority

JP

Japan

Prior art keywords

seq

helix

fragment

residues

fusion polypeptide

Prior art date

2014-01-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 230000004927 fusion Effects 0.000 claims description 83
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 78
• 229920001184 polypeptide Polymers 0.000 claims description 77
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 77
• 239000012634 fragment Substances 0.000 claims description 60
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 44
• 101001002470 Homo sapiens Interferon lambda-1 Proteins 0.000 claims description 43
• 101001002466 Homo sapiens Interferon lambda-3 Proteins 0.000 claims description 43
• 102100020990 Interferon lambda-1 Human genes 0.000 claims description 43
• 102100020992 Interferon lambda-3 Human genes 0.000 claims description 43
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 40
• 102000001708 Protein Isoforms Human genes 0.000 claims description 33
• 108010029485 Protein Isoforms Proteins 0.000 claims description 33
• 108010050904 Interferons Proteins 0.000 claims description 17
• 102000014150 Interferons Human genes 0.000 claims description 17
• 230000001747 exhibiting effect Effects 0.000 claims description 17
• 229940079322 interferon Drugs 0.000 claims description 17
• 238000000034 method Methods 0.000 claims description 10
• 238000012986 modification Methods 0.000 claims description 9
• 230000004048 modification Effects 0.000 claims description 9
• 241000124008 Mammalia Species 0.000 claims description 7
• 239000002202 Polyethylene glycol Substances 0.000 claims description 6
• 125000000539 amino acid group Chemical group 0.000 claims description 6
• 229920001223 polyethylene glycol Polymers 0.000 claims description 6
• 208000036142 Viral infection Diseases 0.000 claims description 5
• 230000009385 viral infection Effects 0.000 claims description 5
• 102220577380 Ras-related protein Rab-22A_Q64L_mutation Human genes 0.000 claims description 3
• 239000008194 pharmaceutical composition Substances 0.000 claims description 3
• 102000040430 polynucleotide Human genes 0.000 claims description 3
• 108091033319 polynucleotide Proteins 0.000 claims description 3
• 239000002157 polynucleotide Substances 0.000 claims description 3
• 102000004169 proteins and genes Human genes 0.000 claims description 3
• 108090000623 proteins and genes Proteins 0.000 claims description 3
• 102220335304 rs1555833051 Human genes 0.000 claims description 3
• 241000801930 Apterona helix Species 0.000 claims description 2
• 102220526454 DNA (cytosine-5)-methyltransferase 3B_R54P_mutation Human genes 0.000 claims description 2
• 102220477327 Protein XRP2_Q31A_mutation Human genes 0.000 claims description 2
• 102220612026 Tyrosine-protein kinase Fer_K37R_mutation Human genes 0.000 claims description 2
• 102220415904 c.104G>A Human genes 0.000 claims description 2
• 102220351305 c.176C>A Human genes 0.000 claims description 2
• 102220355148 c.260A>G Human genes 0.000 claims description 2
• 102220354823 c.28G>C Human genes 0.000 claims description 2
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
• 102200091760 rs1043302 Human genes 0.000 claims description 2
• 102200012566 rs111033665 Human genes 0.000 claims description 2
• 102200039507 rs121918314 Human genes 0.000 claims description 2
• 102220068389 rs201989984 Human genes 0.000 claims description 2
• 102220005490 rs33986902 Human genes 0.000 claims description 2
• 102220005375 rs34269448 Human genes 0.000 claims description 2
• 102220178418 rs367835995 Human genes 0.000 claims description 2
• 102220219140 rs398123324 Human genes 0.000 claims description 2
• 102220047519 rs587777841 Human genes 0.000 claims description 2
• 102220045411 rs587782084 Human genes 0.000 claims description 2
• 102220032023 rs72554321 Human genes 0.000 claims description 2
• 102200101793 rs72554337 Human genes 0.000 claims description 2
• 102220056958 rs730880941 Human genes 0.000 claims description 2
• 102200142361 rs79011243 Human genes 0.000 claims description 2
• 102220072337 rs794728990 Human genes 0.000 claims description 2
• 125000006850 spacer group Chemical group 0.000 claims description 2
• 239000000203 mixture Substances 0.000 claims 2
• 102220484957 Olfactory receptor 4M2_G96E_mutation Human genes 0.000 claims 1
• 150000001413 amino acids Chemical class 0.000 description 4
• 210000004027 cell Anatomy 0.000 description 4
• 206010061218 Inflammation Diseases 0.000 description 3
• 206010028980 Neoplasm Diseases 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 230000004054 inflammatory process Effects 0.000 description 3
• NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
• 206010009944 Colon cancer Diseases 0.000 description 1
• 208000005176 Hepatitis C Diseases 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 229920001427 mPEG Polymers 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1